Published: Jan 07, 2023, 04:01 IST | Updated: Jan 07, 2023, 04:01 IST
China is in talks with Pfizer to secure a licence that will permit domestic drugmakers to manufacture and distribute generic version of the U.S. firm's Covid drug as cases surge. Watch this video to know more.